Le Lézard
Classified in: Health
Subjects: NPT, BLK, MIN, DEI

The Balm In Gilead Presents Prostate Cancer and Black Men Live Webinar


September 12 at 7:00pmET 

RICHMOND, Va., Sept. 12, 2023 /PRNewswire/ -- In efforts to drive awareness about health disparities in the United States that result in higher rates of prostate cancer diagnosis and death for Black men, The Balm In Gilead, Inc., a national non-profit organization, will present a free webinar titled "Talk That Talk: Prostate Cancer and Black Men" on September 12, 2023  at 7:00pmET via Zoom. Registration is required.

"Because one in six Black men will be diagnosed with prostate cancer, our webinar will examine gaps in awareness and knowledge that contribute to delays in Black men seeking screening and treatment for this disease," said Pernessa C. Seele, Ph.D., founder and CEO of The Balm In Gilead, Inc.  

Dr. Seele will host the webinar, which features an esteemed panel moderated by Rev. Dr. Nathaniel T. Brooks, senior pastor, Greater St. John Baptist Church, Birmingham, AL,  who is a leader in community cancer education. Joining him will be Terrence S. Richardson, MBA, a patient advocate and champion committed to helping patients and families manage their cancer journey, and Dr. Russell J. Ledet, MD, PhD, MBA, Triple Board Resident at Indiana University.

Black men are two to four times more likely to die of prostate cancer than other ethnic groups.2 To help address this health disparity, The Balm In Gilead encourages Black men to talk to their doctors about getting screened for prostate cancer on a regular basis.

The Balm In Gilead, Inc. is a 35-year-old organization whose mission is to improve the health status of people of African descent by providing resources and technical support to faith institutions. Learn more at The Balm In Gilead. 

The "Talk That Talk" webinar is presented with support from the Janssen Pharmaceutical Companies of Johnson & Johnson's Talk That Talktm, an educational campaign and call to action to drive prostate cancer awareness and reinforce the importance of screening for early detection among Black men. Learn more at www.janssen.com

Please register for the webinar here.

1 In consideration for his time, Dr. Russell J. Ledet, MD, PhD, MBA was paid an honorarium by Janssen.

2. Siegel, RL, Miller, KD, Wagle, NS, Jemal, A. Cancer statistics, 2023.  doi:10.3322/caac.21763

 

SOURCE Balm In Gilead, Inc.


These press releases may also interest you

at 18:42
George Weston Limited ("Weston" or the "Company") today announced that all of the nominee directors listed in its management proxy circular dated March 19, 2024, were elected as directors of the Company. The vote was conducted at the Company's...

at 18:41
Family Source Consultants, LLC, a leading provider of surrogacy, egg donation, and all third-party reproduction services, is excited to announce the grand opening of its new state-of-the-art office dedicated to enhancing the journeys of intended...

at 18:15
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024....

at 18:00
In recognition of Mother's Day on May 12th, Denny's Canada is delighted to announce that they have partnered with Women's Health Collective Canada (WHCC) to host a special fundraiser. From May 7th to 12th, in participating stores across Canada, $2...

at 17:41
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the publication in JAMA Cardiology of two-year echocardiographic data from its REDUCE LAP-HF II randomized clinical trial of the Corvia® Atrial...

at 17:09
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for...



News published on and distributed by: